Skip to content

Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients

Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02737540
Acronym
SPAD
Enrollment
85
Registered
2016-04-14
Start date
2017-08-16
Completion date
2020-11-30
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder, Major

Brief summary

The main objective of this study is to confirm the existence of risky decision making in a non strategic situation (Iowa Gambling Task) and a deficit of decision making in social situations, linked to greater sensitivity to injustice (Ultimatum Game) and a lower level of trust (Trust Game) in elderly depressed patients with a history of suicide attempts in comparison with older depressed patients without a history of suicidal acts and healthy subjects.

Detailed description

The secondary objectives are to confirm or explore the deficits of certain cognitive processes involved in potentially suicidal behavior in depressed elderly persons but that have been little or not studied to date. These include: A. cognitive control and sensitivity to interference (Victoria Stroop test, incompatibility test, flexibility test, Go / No-Go); B. Strategic recovery of semantic memory (verbal fluency test); C. Working memory (TEA); D. Insight related to depression (Mood Disorders Insight Scale); E. Recognition of facial emotions; F. Emotional regulation; G. Negative attitudes; H. Self-perception and; I. Time perspectives. Finally, patients will be contacted by telephone at month 6 to assess the occurrence of a suicidal act during this period and thus calculate the predictive ability of cognitive and psychological factors.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for patients: * The patient or his/her representative must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * Patients with a diagnosis of current, moderate to severe, major depressive episode according to the DSM diagnostic criteria 5. This episode can be considered as part of a major depressive disorder or bipolar disorder. * Patients with or without a personal history of suicide attempts. A suicide attempt is defined as any act performed with some intent to die (Mann 1998). Suicidal threats, aborted or interrupted gestures as well as self-mutilating acts without suicidal intent will not be considered as suicidal acts. * Patients hospitalized (or followed as outpatients) in the Nîmes University Hospital psychiatry department or the Sophoras clinic in Nimes Inclusion criteria for healthy subjects: * The subject or his/her representative must have given his/her informed and signed consent * The subject must be insured or beneficiary of a health insurance plan * Non-depressed subject without personal history of lifetime mood disorder or severe mental illness, or substance or alcohol abuse during the past 12 months

Exclusion criteria

for patients: * The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection * The patient (or his/her legal representative) refuses to sign the consent * It is impossible to correctly inform the patient or his/her legal representative * The patient has a known MMSE score \<24 (elimination of probable dementia pathology) * Known central neurological disease including degenerative disease, severe head trauma and severe cerebral vascular disease * Known schizophrenia and other psychotic disorders * Alcohol or substance abuse in the last 12 months * Electroconvulsive therapy in the 12 months preceding the study because of the risk of mnesic side effects * Inability to perform neuropsychological tests because of a language problem, poor understanding, a major tremor, inability to sit still, a major sight problem that can not be corrected, or other severe cognitive impairment * The subject presents an acute somatic decompensation incompatible with the completion of this study * The patient has current confusion

Design outcomes

Primary

MeasureTime frame
Trust GameDays 1-7
Ultimatum GameDays 1-7
Iowa Gambling TaskDays 1-7

Secondary

MeasureTime frame
Go-NoGoDays 1-7
Working memory - TEADays 1-7
Mood Disorders Insight ScaleDays 1-7
Verbal fluency testDays 1-7
Future autobiographical fluency taskDays 1-7
Stroop Victoria TestDays 1-7
Cognitive Emotion Regulation QuestionnaireDays 1-7
Questionnaire on negative attitudes towards problemsDays 1-7
Revised self-awareness scale, Self-reference taskDays 1-7
Balanced Temporal Perspective ScaleDays 1-7
Suicide attempt within 6 months of follow-upMonth 6
Bristol Emotion Recognition TestDays 1-7
Incompatibility TestDays 1-7
Flexibility testDays 1-7

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026